Akari Therapeutics Plc (AKTX) bonds
AKTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 0/30
$6.65+0.95 (+16.67%)
Close on Nov 18, 2026Market cap $12.95MP/E –Yield –
Debt
Borrowings on the balance sheet, Jun 30, 2026
Akari Therapeutics reports no long-term debt line
Its balance sheet in XBRL does not include long-term debt, so totals and interest cost cannot be shown.
Notes and loans outstanding
As tagged in Akari Therapeutics's 10-K for the period ended Dec 31, 2025
| Issue | Coupon | Amount issued | Carrying value |
|---|---|---|---|
| April Two Thousand Twenty Three Convertible Notes Convertible at $0 a share | 10.00% | – | – |
| August Two Thousand Twenty Five Notes | – | $3.76M | – |
| January Two Thousand Twenty Four Note | – | – | $0 |
| January Two Thousand Twenty Four Notes | 15.00% | – | – |
| Two Thousand Twenty One Notes | 1.00% | – | – |
Companies tag their debt differently: some list every note, others group notes by issuance year or by type, so the list may not add up to total debt. Notes that matured before today are hidden. Source: 10-K.
See a number that looks wrong?